Johns Hopkins Diabetes GuideManagementType 1 Diabetes

Insulin Pump Management

Nestoras Mathioudakis, M.D., MHS, Saira Khan, M.D.
Insulin Pump Management is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

DEFINITION

  • Insulin pumps (technically called Continuous Subcutaneous Insulin Infusion, CSII) deliver insulin at programmed rates, from a pump worn externally through a small catheter tip inserted into the skin.
  • May be linked to a continuous glucose monitor (CGM), displaying real-time BG results, but insulin delivery is not driven by the blood glucose (BG) result; fully closed loop delivery system does not currently exist. Insulin delivery rates and amounts are determined by the patient.
  • However, some newer models include an insulin pump/CGM combo that provides a Threshold Suspend Feature, which suspends insulin delivery for up to 2 hours when the sensor glucose value reaches a preset low. This is a useful safety feature for patients with severe hypoglycemia unawareness.
  • CSII is an option for treating type 1 diabetes or unstable, insulin-requiring type 2 diabetes.
  • Only use rapid-acting (e.g. aspart, lispro or glulisine) or regular insulin (U-100 or U-500).

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 1, 2016